ANGPTL8 is a negative regulator in pathological cardiac hypertrophy
Abstract Pathological cardiac hypertrophy is an independent risk factor for heart failure and is considered a target for the treatment of heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. We aimed to investigate the role of angiopoietin-like p...
Main Authors: | Lin Hu, Jiarui Wei, Yue Zhang, Ziyuan Wang, Junming Tang, Jian Tang, Yujiu Gao, Xiaoqiao Zhang, Yifan Li, Yantong Liu, Shinan Ma, Xingrong Guo, Qiufang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-07-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05029-8 |
Similar Items
-
ANGPTL8 promotes adipogenic differentiation of mesenchymal stem cells: potential role in ectopic lipid deposition
by: Jian Tang, et al.
Published: (2022-08-01) -
ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways
by: Zongli Zhang, et al.
Published: (2023-05-01) -
Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis
by: Yujiu Gao, et al.
Published: (2023-05-01) -
Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postprandial Triglyceride-Rich Lipoprotein (TRL)
by: Zhang T, et al.
Published: (2023-12-01) -
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
by: Ke-Qiong Deng, et al.
Published: (2016-06-01)